Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Bio-business and Medical Sciences MSc    Back

University of Aberdeen Course Type: Master taught Start Date: September
Location: Aberdeen, United Kingdom Duration: see details Fees/total cost: EUR 6,072.30 (GBP 4,500.00) - EUR 23,209.68 (GBP 17,200.00)

Description

Overview

The University of Aberdeen has an impressive reputation for producing successful spin-out companies in the broad area of biotechnology and pharmacology.

This MSc has harnessed these skills to provide you with an understanding of the commercialisation of scientific ideas, the setting up of a bio-business and the research skills that are needed to accompany this knowledge. Selection of discipline -specific knowledge to complement the core elements of the programme is up to you, giving you a unique opportunity to follow your interests within science.

This MSc is ideal for graduates in biomedical science, pharmacy and medicine who want to improve their career prospects, widen their knowledge base linked to their own scientific interests and are fascinated by the commercialisation of science.

What You'll Study

The information below applies to the 1 year full time / 2 year part time on campus learning MSc programme which runs in September.

Semester 1

Compulsory Courses

Introduction to Bio - Business and the Commercialisation of Bioscience Research (BT5012)

This course will describe the basic language of business and give examples of large versus small businesses in the bioscience area. Intellectual property rights will be explained as will how present your business and how to set up a small biotech company. A comparison will be made of the big Pharma business model and that of small biotech businesses.

Generic Skills (GS50M1)

This course will improve your employability skills. I-SEE (Individualised self-assessment to enhance employability) is a bespoke online resource developed to help identify your strengths and areas needing improvement. The self-assessment process allows you to identify development areas for employability skills like communication, IT and numeracy skills and personal attributes like creativity, organisation and timekeeping, flexibility, team working. This leads to automated, tailored feedback and signposting to self-study to assist in improving your CV. Reflection and an e-portfolio will assist in articulation of these enhanced skills/attributes during mock interviews. Some sessions are compulsory, but otherwise it involves self-directed learning.

Basic Skills - Induction (MT5010)

This course is designed to provide or revise the basic skills you will require for your MSc. The course will revise basic laboratory skills and techniques and advance these to a level required to undertake graduate practical classes and projects by developing hands-on experience, competence and confidence in key laboratory skills. An expert from the library will explain the use and facilities of the library and the basics of database searching to enhance research skills and project validation.

Optional Courses

Plus three courses from the following list:

Drug Metabolism & Toxicology (MT5003)

This course provides advanced level drug metabolism and includes the importance of drug transporters in the drug discovery process, dealing with molecular toxicology and pharmacology at an advanced level. Mechanisms of drug and oxidative stress and immunopharmacology are described. External experts are invited to provide their unique expertise on a range of topics which can include toxicopathology, immunotoxicology, risk assessment and an industrial perspective on the drug discovery process.

Molecular Pharmacology (MT5024)

This course will cover a wide range of topics and will include revision of receptor theory and intra- and inter- cellular communication. Cancer will be used a s model disease and the molecular basis of cancer, how it is treated, clinical issues, drug resistance and chemotherapy and prevention.

Small Molecule Drug Discovery (BT5013)

The course will focus on small molecule drug discovery. Receptor theory and cell communication and signalling will be revised to facilitate understanding of the remainder of the course. The basis of the drug discovery process will be described and the phases of drug development discussed. A range of targets for drug discovery will be identified and how small molecule drug affect these will be described. Issues around drug regulation will be raised.

Therapeutics (MT5027)

This course will describe and review the use of medicinal compounds in man together with methods to assess and describe efficacy and toxicity. A number of exemplar disease areas and at risk populations will be selected and the drugs used to treat these conditions and populations discussed and explained. The importance of understand drug mechanisms of action and associated risk as well as benefit will be emphasised in a clinical setting. The course will consider both drugs in current use and those in development.

Introduction to Molecular Biology (MB5022)

This is an introductory course in molecular biology basics for all taught postgraduate programmes with a molecular biology content. It aims to ensure that PG taught course students, with diverse educational backgrounds, on programmes with a substantial molecular biology content, have an adequate knowledge of the basic concepts and techniques of molecular biology. There is a practical element with this course.

Semester 2

Compulsory Courses

Advanced Bio - Business and the Commercialisation of Bioscience Research (BT5508)

This advanced course builds on the basics provided in Introduction to Bio-business and the Commercialisation of Bioscience Research (BT5012). It provides more detail on financing and setting up a Bio-business.

The course deals in depth with finance, corporate governance and business models. The major assessment involves the students working together in teams to set up a virtual bio-business and to pitch this business to a group of experts in the pharmaceutical and biotechnology sector. The team will adopt the roles of senior management team and present to the experts their part of the business.

Biologic Drug Discovery (BT5509)

This course is aimed at the understanding of novel areas of drug discovery with the specific aim of understanding the roles immunology and peptide chemistry play in informing the development of antibody and small molecule peptide-based biologic therapies for diverse diseases.

Basic Research Methods (MT5515)

This course reviews a range of methodologies that are currently used in basic research. Experts in the various techniques describe the methodology and showcase the equipment.

Optional Courses

Plus at least 30 credits from the following list:

Pharmacovigilance (MT5501)

The will comprise lectures, tutorials and seminars. The curriculum will provide an in-depth look at pharmacovigilance using examples from both first and third world countries and will include detection of adverse drug reactions; causality assessment; prevention of adverse drug reactions including correct prescribing, prevention of drug errors and promotion of rational drug use; and communication of risk-benefit information to the general public.

Pharmacokinetics (MT5518)

Pharmacokinetics describe “what the body does to a drug” and thus is a central feature of applied pharmacology. The course will develop an understanding of the role that pharmacokinetics play in all aspects of drug administration, distribution, metabolism and excretion and how these effects can be modelled and predicted graphically and mathematically. Such modelling is a fundament of therapeutic regimen design, drug development, clinical pharmacology and drug safety and will be considered within all of these contexts providing a broad and relevant appreciation of the importance of pharmacokinetics to the pharmacologist.

Semester 3

Compulsory Courses

Research Project 2 (MT5903)

The research project is the climax of the MSc programme and involves working on an independent research project for 12 weeks prior to completion of a dissertation. It involves utilisation of much of the skills developed throughout the previous 2 semesters, and is selected based on student interests and preferences.

Masters - Full time

Start date:
September
Duration:
1 Year
Teaching method:
Face-To-Face
Language:
English
Venue:
Aberdeen, United Kingdom
Funding possible:
Yes
EU-Fees:
EUR 6,072.30 (GBP 4,500.00)
Non-EU-Fees:
EUR 23,209.68 (GBP 17,200.00)
Additional Information:
Fees 2016/17

Masters - Part time

Start date:
September
Duration:
2 Years
Teaching method:
Face-To-Face
Language:
English
Venue:
Aberdeen, United Kingdom
Funding possible:
Yes

Course Provider Details

Course contact information


College of Life Sciences and Medicine Graduate School
graduateschool-clsm@abdn.ac.uk
University accredited:
Last update: 23/08/2016
Feedback lifetrain.eu